{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:38:48Z","timestamp":1790422728100,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00240-016-0953-y","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T16:15:02Z","timestamp":1480436102000},"page":"43-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Do \u201cinhibitors of crystallisation\u201d play any role in the prevention of kidney stones? A critique"],"prefix":"10.1007","volume":"45","author":[{"given":"William G.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"953_CR1","first-page":"412","volume":"6","author":"TA Borden","year":"1969","unstructured":"Borden TA, Lyon ES (1969) The effects of magnesium and pH on experimental calcium oxalate stone disease. Invest Urol 6:412\u2013422","journal-title":"Invest Urol"},{"key":"953_CR2","first-page":"36","volume":"13","author":"JL Meyer","year":"1975","unstructured":"Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 13:36\u201339","journal-title":"Invest Urol"},{"key":"953_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1152\/ajplegacy.1962.203.4.671","volume":"203","author":"H Fleisch","year":"1962","unstructured":"Fleisch H, Bisaz S (1962) Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203:671\u2013675","journal-title":"Am J Physiol"},{"key":"953_CR4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF02151805","volume":"20","author":"H Fleisch","year":"1964","unstructured":"Fleisch H, Bisaz S (1964) The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis. Experientia 20:276\u2013277","journal-title":"Experientia"},{"key":"953_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02059063","volume":"15","author":"JL Meyer","year":"1974","unstructured":"Meyer JL, McCall JT, Smith LH (1974) Inhibition of calcium phosphate crystallization by nucleoside phosphates. Calcif Tissue Res 15:289\u2013293","journal-title":"Calcif Tissue Res"},{"key":"953_CR6","first-page":"119","volume":"120","author":"JE Howard","year":"1967","unstructured":"Howard JE, Thomas WC, Barker LM, Smith LH, Wadkins CL (1967) The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J 120:119\u2013136","journal-title":"Johns Hopkins Med J"},{"key":"953_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0009-8981(73)90114-9","volume":"43","author":"WG Robertson","year":"1973","unstructured":"Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31\u201337","journal-title":"Clin Chim Acta"},{"key":"953_CR8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0009-8981(81)90458-7","volume":"112","author":"RL Ryall","year":"1981","unstructured":"Ryall RL, Harnett RM, Marshall VR (1981) The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 112:349\u2013356","journal-title":"Clin Chim Acta"},{"key":"953_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0022-0248(81)90064-6","volume":"53","author":"WG Robertson","year":"1981","unstructured":"Robertson WG, Scurr DS, Bridge CM (1981) Factors influencing the crystallization of calcium oxalate in urine\u2014a critique. J Crystal Growth 53:182\u2013194","journal-title":"J Crystal Growth"},{"key":"953_CR10","first-page":"267","volume":"13","author":"EM Worcester","year":"1987","unstructured":"Worcester EM, Nakagawa Y, Coe FL (1987) Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab 13:267\u2013272","journal-title":"Miner Electrolyte Metab"},{"key":"953_CR11","first-page":"F1197","volume":"255","author":"EM Worcester","year":"1988","unstructured":"Worcester EM, Nakagawa Y, Wabner CL, Kumar S, Coe FL (1988) Crystal adsorption and growth slowing by nephrocalcin, albumin and Tamm\u2013Horsfall protein. Am J Physiol 255:F1197\u2013F1205","journal-title":"Am J Physiol"},{"key":"953_CR12","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1172\/JCI113019","volume":"79","author":"Y Nakagawa","year":"1987","unstructured":"Nakagawa Y, Ahmed MA, Hall SL, Deganello S, Coe FL (1987) Isolation from human calcium oxalate stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest 79:1782\u20131787","journal-title":"J Clin Invest"},{"key":"953_CR13","first-page":"F99","volume":"257","author":"B Hess","year":"1989","unstructured":"Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99\u2013F106","journal-title":"Am J Physiol"},{"key":"953_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.1990.252","volume":"38","author":"FL Coe","year":"1990","unstructured":"Coe FL, Parks JH (1990) Defenses of an unstable compromise: crystallization inhibitors and the kidney\u2019s role in mineral regulation. Kidney Int 38:625\u2013631","journal-title":"Kidney Int"},{"key":"953_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00393304","volume":"23","author":"B Hess","year":"1995","unstructured":"Hess B, Meinhardt U, Zipperle L, Giovanoli R, Jaeger P (1995) Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 23:231\u2013238","journal-title":"Urol Res"},{"key":"953_CR16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1073\/pnas.89.1.426","volume":"89","author":"H Shiraga","year":"1992","unstructured":"Shiraga H, Min W, Van Dusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426\u2013430","journal-title":"Proc Natl Acad Sci USA"},{"key":"953_CR17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1442-2042.2007.01783.x","volume":"14","author":"H Tsuji","year":"2007","unstructured":"Tsuji H, Tohru U, Hirotsugu U, Masanori I, Yuji H, Takashi K (2007) Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation. Int J Urol 14:630\u2013634","journal-title":"Int J Urol"},{"key":"953_CR18","first-page":"F255","volume":"275","author":"SN Pillay","year":"1998","unstructured":"Pillay SN, Asplin JR, Coe FL (1998) Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol 275:F255\u2013F261","journal-title":"Am J Physiol"},{"key":"953_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002400050117","volume":"27","author":"S Tardivel","year":"1999","unstructured":"Tardivel S, M\u00e9d\u00e9tognon J, Randoux C, K\u00e9b\u00e9d\u00e9 M, Dr\u00fceke T, Daudon M, Hennequin C, Lacour B (1999) Alpha-1-microglobulin: inhibitory effect on calcium oxakate crystallization in vitro and decreased urinary excretion in calcium oxalate stone formers. Urol Res 27:243\u2013249","journal-title":"Urol Res"},{"key":"953_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00298850","volume":"23","author":"B Dussol","year":"1995","unstructured":"Dussol B, Geider S, Lilova A, Leonetti F, Dupuy P, Daudon M, Berland Y, Dagorn JC, Verdier JM (1995) Analysis of the soluble matrix of five morphologically different kidney stones. Urol Res 23:45\u201351","journal-title":"Urol Res"},{"issue":"11","key":"953_CR21","doi-asserted-by":"publisher","first-page":"e80344","DOI":"10.1371\/journal.pone.0080344","volume":"8","author":"M Goiko","year":"2011","unstructured":"Goiko M, Dierolf J, Gleberzon JS, Liao Y, Grohe B, Goldberg HA, de Bruyn JR, Hunter GK (2011) Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One 8(11):e80344. doi: 10.1371\/journal.pone.0080344","journal-title":"PLoS One"},{"key":"953_CR22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.1996.121","volume":"49","author":"AM Stapleton","year":"1996","unstructured":"Stapleton AM, Dawson CJ, Grover PK, Hohmann A, Comacchio R, Boswarva V, Tang Y, Ryall RL (1996) Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix. Kidney Int 49:880\u2013888","journal-title":"Kidney Int"},{"key":"953_CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1432-1327.1999.00448.x","volume":"263","author":"PK Grover","year":"1999","unstructured":"Grover PK, Ryall RL (1999) Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Eur J Biochem 263:50\u201356","journal-title":"Eur J Biochem"},{"key":"953_CR24","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.juro.2007.11.041","volume":"179","author":"V Thongboonkerd","year":"2008","unstructured":"Thongboonkerd V, Chutipongtanate S, Semangoen T, Malasit P (2008) Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation. J Urol 179:1615\u20131619","journal-title":"J Urol"},{"key":"953_CR25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1464-410x.1998.00515.x","volume":"81","author":"CJ Dawson","year":"1998","unstructured":"Dawson CJ, Grover PK, Ryall RL (1998) Inter-alpha-inhibitor in urine and calcium oxalate urinary crystals. Br J Urol 81:20\u201326","journal-title":"Br J Urol"},{"key":"953_CR26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.ki.5002569","volume":"72","author":"AP Evan","year":"2007","unstructured":"Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503\u20131511","journal-title":"Kidney Int"},{"key":"953_CR27","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2741\/1181","volume":"8","author":"WG Robertson","year":"2003","unstructured":"Robertson WG (2003) A risk factor model of stone-formation. Front Biosci 8:1330\u20131338","journal-title":"Front Biosci"},{"key":"953_CR28","first-page":"383","volume":"4","author":"S Nishio","year":"2000","unstructured":"Nishio S, Hatanaka M, Takeda H, Aoki K, Iseda T, Iwata H, Yokoyama M (2000) Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. Mol Urol 4:383\u2013390","journal-title":"Mol Urol"},{"key":"953_CR29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1749-6632.1963.tb17693.x","volume":"104","author":"WH Boyce","year":"1963","unstructured":"Boyce WH, King JS (1963) Present concepts concerning the origin of matrix and stones. Ann N Y Acad Sci 104:563\u2013578","journal-title":"Ann N Y Acad Sci"},{"key":"953_CR30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0022-5347(17)42665-6","volume":"139","author":"RM Morse","year":"1988","unstructured":"Morse RM, Resnick MI (1988) A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139:869\u2013873","journal-title":"J Urol"},{"key":"953_CR31","first-page":"387","volume":"13","author":"AR Spector","year":"1976","unstructured":"Spector AR, Gray A, Prien EL (1976) Kidney stone matrix. Differences in acidic protein composition. Invest Urol 13:387\u2013389","journal-title":"Invest Urol"},{"key":"953_CR32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI108739","volume":"59","author":"JB Lian","year":"1977","unstructured":"Lian JB, Prien EL, Glimcher MJ, Gallop PM (1977) The presence of protein-bound c-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest 59:1151\u20131157","journal-title":"J Clin Invest"},{"key":"953_CR33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-5347(17)39648-9","volume":"144","author":"WT Jones","year":"1990","unstructured":"Jones WT, Resnick MI (1990) The characterization of soluble matrix proteins in selected human renal calculi using two-dimensional polyacrylamide gel electrophoresis. J Urol 144:1010\u20131014","journal-title":"J Urol"},{"key":"953_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(17)53656-3","volume":"127","author":"GA Rose","year":"1982","unstructured":"Rose GA, Sulaiman S (1982) Tamm\u2013Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies. J Urol 127:177\u2013179","journal-title":"J Urol"},{"key":"953_CR35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(17)44931-7","volume":"136","author":"DS Scurr","year":"1986","unstructured":"Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. III. Studies on the role of Tamm\u2013Horsfall mucoprotein and of ionic strength. J Urol 136:505\u2013507","journal-title":"J Urol"},{"key":"953_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/la00051a028","volume":"7","author":"A Ebrahimpour","year":"1991","unstructured":"Ebrahimpour A, Perez L, Nancollas GH (1991) Induced crystal growth of calcium oxalate monohydrate at hydroxyapatite surfaces. The influence of human serum albumin, citrate and magnesium. Langmuir 7:577\u2013583","journal-title":"Langmuir"},{"key":"953_CR37","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1046\/j.1523-1755.1999.00426.x","volume":"55","author":"C Cerini","year":"1999","unstructured":"Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berth\u00e9z\u00e8ne P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM (1999) Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stones. Kidney Int 55:1776\u20131786","journal-title":"Kidney Int"},{"key":"953_CR38","doi-asserted-by":"publisher","first-page":"12648","DOI":"10.1021\/ja505402r","volume":"136","author":"S Farmanesh","year":"2014","unstructured":"Farmanesh S, Chung J, Sosa RD, Kwak JH, Karande P, Rimer JD (2014) Natural promoters of calcium oxalate monohydrate crystallization. J Am Chem Soc 136:12648\u201312657. doi: 10.1021\/ja505402r","journal-title":"J Am Chem Soc"},{"key":"953_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/292953","author":"KP Aggarwal","year":"2013","unstructured":"Aggarwal KP, Narula S, Kakkar M, Tandon C (2013) Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int. doi: 10.1155\/2013\/292953","journal-title":"Biomed Res Int"},{"key":"953_CR40","doi-asserted-by":"crossref","unstructured":"Kok DJ, Boellaard W, Ridwan Y, Levchenko VA (2017) Timelines of the \u201cfree-particle\u201d and \u201cfixed-particle\u201d models of stone-formation: theoretical and experimental investigations. Urolithiasis (this issue)","DOI":"10.1007\/s00240-016-0946-x"},{"key":"953_CR41","doi-asserted-by":"crossref","unstructured":"Rimer JD, Kolbach-Mandel AM, Ward MD, Wesson JA (2017) The role of macromolecules in the formation of kidney stones. Urolithiasis (this issue)","DOI":"10.1007\/s00240-016-0948-8"},{"key":"953_CR42","first-page":"446","volume":"17","author":"ME Sheehan","year":"1980","unstructured":"Sheehan ME, Nancollas GH (1980) Calcium oxalate crystal growth. A new constant composition method for modelling urinary stone formation. Invest Urol 17:446\u2013450","journal-title":"Invest Urol"},{"key":"953_CR43","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1021\/ja00525a015","volume":"102","author":"P Koutsoukos","year":"1980","unstructured":"Koutsoukos P, Amjad Z, Tomson MB, Nancollas GH (1980) Crystallization of calcium phosphates. A constant composition study. J Am Chem Soc 102:1553\u20131557","journal-title":"J Am Chem Soc"},{"key":"953_CR44","first-page":"258","volume":"9","author":"B Finlayson","year":"1972","unstructured":"Finlayson B (1972) The concept of a continuous crystallizer. Its theory and application to in vivo and in vitro urinary tract models. Invest Urol 9:258\u2013263","journal-title":"Invest Urol"},{"key":"953_CR45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-5347(17)54054-9","volume":"127","author":"GW Drach","year":"1982","unstructured":"Drach GW, Kraljevich Z, Randolph AD (1982) Effects of high molecular weight urinary macromolecules on crystallization of calcium oxalate dihydrate. J Urol 127:805\u2013810","journal-title":"J Urol"},{"key":"953_CR46","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0022-5347(17)46084-8","volume":"135","author":"WG Robertson","year":"1986","unstructured":"Robertson WG, Scurr DS (1986) Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine. J Urol 135:1322\u20131326","journal-title":"J Urol"},{"key":"953_CR47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-5347(17)44756-2","volume":"136","author":"DS Scurr","year":"1986","unstructured":"Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. II. Studies on their mode of action in an artificial urine. J Urol 136:128\u2013131","journal-title":"J Urol"},{"key":"953_CR48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-0248(86)90369-6","volume":"76","author":"R Azoury","year":"1986","unstructured":"Azoury R, Garside J, Robertson WG (1986) Habit modifiers of calcium oxalate crystals precipitated in a reverse osmosis system. J Cryst Growth 76:259\u2013262","journal-title":"J Cryst Growth"},{"key":"953_CR49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1464-410X.2009.08816.x","volume":"105","author":"PK Grover","year":"2010","unstructured":"Grover PK, Thurgood LA, Wang T, Ryall RL (2010) The effects of intra-crystalline and surface-bound proteins on the attachment of calcium oxalate monohydrate crystals to renal cells in undiluted human urine. BJU Int 105:708\u2013715","journal-title":"BJU Int"},{"key":"953_CR50","unstructured":"Robertson WG (1969) Physico-chemical aspects of renal stone-formation. PhD Thesis, University of Leeds, Leeds, UK"},{"key":"953_CR51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02547230","volume":"11","author":"WG Robertson","year":"1973","unstructured":"Robertson WG (1973) Factors affecting the precipitation of calcium phosphate in vitro. Calcif Tissue Res 11:311\u2013322","journal-title":"Calcif Tissue Res"},{"key":"953_CR52","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.68.7.1456","volume":"68","author":"CY Pak","year":"1971","unstructured":"Pak CY, Eanes ED, Ruskin B (1971) Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate. Proc Natl Acad Sci USA 68:1456\u20131460","journal-title":"Proc Natl Acad Sci USA"},{"key":"953_CR53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ki.1975.23","volume":"7","author":"CY Pak","year":"1975","unstructured":"Pak CY, Ohata M, Holt K (1975) Effect of diphosphonate on crystallization of calcium oxalate in vitro. Kidney Int 7:154\u2013160","journal-title":"Kidney Int"},{"key":"953_CR54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1464-410X.1996.00602.x","volume":"78","author":"N Bouropoulos","year":"1996","unstructured":"Bouropoulos N, Bouropoulos C, Klepetsanis PG, Melekos M, Barbalias G, Koutsoukos PG (1996) A model system for the investigation of urinary stone formation. Br J Urol 78:169\u2013175","journal-title":"Br J Urol"},{"issue":"Suppl","key":"953_CR55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF02065192","volume":"2","author":"H Fleisch","year":"1968","unstructured":"Fleisch H, Russell RG, Bisaz S, Casey PA, M\u00fchlbauer RC (1968) The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution. Calcif Tissue Res 2(Suppl):10\u201310a","journal-title":"Calcif Tissue Res"},{"key":"953_CR56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0304-4165(70)90198-4","volume":"222","author":"WG Robertson","year":"1970","unstructured":"Robertson WG, Fleisch H (1970) Imidodiphosphate: an inhibitor of in vitro precipitation and the dissolution of calcium phosphate. Biochim Biophys Acta 222:677\u2013680","journal-title":"Biochim Biophys Acta"},{"key":"953_CR57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0009-8981(69)90152-1","volume":"24","author":"WG Robertson","year":"1969","unstructured":"Robertson WG (1969) Measurement of ionized calcium in biological fluids. Clin Chim Acta 24:149\u2013157","journal-title":"Clin Chim Acta"},{"key":"953_CR58","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0022-5347(17)47703-2","volume":"134","author":"PG Werness","year":"1985","unstructured":"Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134:1242\u20131244","journal-title":"J Urol"},{"issue":"Suppl 1","key":"953_CR59","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/s00240-014-0737-1","volume":"43","author":"WG Robertson","year":"2015","unstructured":"Robertson WG (2015) Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall\u2019s Plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis 43(Suppl 1):S93\u2013S107","journal-title":"Urolithiasis"},{"key":"953_CR60","first-page":"294","volume":"96","author":"CY Pak","year":"1983","unstructured":"Pak CY, Sakhaee K, Fuller CJ (1983) Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Trans Assoc Am Physicians 96:294\u2013305","journal-title":"Trans Assoc Am Physicians"},{"key":"953_CR61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5347(17)46962-X","volume":"134","author":"CY Pak","year":"1985","unstructured":"Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F (1985) Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11\u201319","journal-title":"J Urol"},{"key":"953_CR62","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0022-5347(01)68155-2","volume":"158","author":"B Ettinger","year":"1997","unstructured":"Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium\u2013magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069\u20132073","journal-title":"J Urol"},{"key":"953_CR63","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-5347(17)55655-4","volume":"124","author":"G Johansson","year":"1980","unstructured":"Johansson G, Backman U, Danielson BG, Fellstr\u00f6m B, Ljunghall S, Wikstr\u00f6m B (1980) Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124:770\u2013774","journal-title":"J Urol"},{"key":"953_CR64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0022-5347(17)39924-X","volume":"143","author":"J Lindberg","year":"1990","unstructured":"Lindberg J, Harvey J, Pak CYC (1990) Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food\u2013magnesium interaction. J Urol 143:248\u2013251","journal-title":"J Urol"},{"key":"953_CR65","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.urology.2012.06.033","volume":"80","author":"BH Eisner","year":"2012","unstructured":"Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr (2012) High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology 80:780\u2013783","journal-title":"Urology"},{"key":"953_CR66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/003655900750016869","volume":"34","author":"C Jendle-Bengten","year":"2000","unstructured":"Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone-formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36\u201341","journal-title":"Scand J Urol Nephrol"},{"key":"953_CR67","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2215\/CJN.11321210","volume":"6","author":"FL Coe","year":"2011","unstructured":"Coe FL, Evan A, Worcester (2011) Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083\u20132092","journal-title":"Clin J Am Soc Nephrol"},{"key":"953_CR68","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1681\/ASN.2014121223","volume":"26","author":"NS Krieger","year":"2015","unstructured":"Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA (2015) Effect of potassium citrate on calcium phosphate stones in a model of hypercalciuria. J Am Soc Nephrol 26:3001\u20133008","journal-title":"J Am Soc Nephrol"},{"key":"953_CR69","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","volume":"212","author":"H Fleisch","year":"1966","unstructured":"Fleisch H, Russell RG, Straumann F (1966) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212:901\u2013903","journal-title":"Nature"},{"key":"953_CR70","first-page":"435","volume":"51","author":"RG Russell","year":"1976","unstructured":"Russell RG, Bisaz S, Fleisch H (1976) The influence of orthophosphate on the renal handling of inorganic pyrophosphate in man and dog. Clin Sci Mol Med 51:435\u2013443","journal-title":"Clin Sci Mol Med"},{"key":"953_CR71","first-page":"253","volume":"53","author":"LH Smith","year":"1980","unstructured":"Smith LH, Werness PG, Van Den Berg CJ, Wilson DM (1980) Orthophosphate treatment in calcium urolithiasis. Scand J Urol Nephrol Suppl 53:253\u2013263","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"953_CR72","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem-51-5-998","volume":"51","author":"CJ Berg Van Den","year":"1980","unstructured":"Van Den Berg CJ, Kumar R, Wilson DM, Heath H 3rd, Smith LH (1980) Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 51:998\u20131001","journal-title":"J Clin Endocrinol Metab"},{"key":"953_CR73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000182872","volume":"32","author":"PJ Heyburn","year":"1982","unstructured":"Heyburn PJ, Robertson WG, Peacock M (1982) Phosphate treatment of recurrent calcium stone disease. Nephron 32:314\u2013319","journal-title":"Nephron"},{"key":"953_CR74","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199412083312304","volume":"331","author":"DS Milliner","year":"1994","unstructured":"Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH (1994) Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331:1553\u20131558","journal-title":"N Engl J Med"},{"key":"953_CR75","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000086358","volume":"25","author":"B Hoppe","year":"2005","unstructured":"Hoppe B, Latta K, von Schnakenburg C, Kemper MJ (2005) Primary hyperoxaluria\u2014the German experience. Am J Nephrol 25:276\u2013281","journal-title":"Am J Nephrol"},{"key":"953_CR76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/cs0420197","volume":"42","author":"D Fraser","year":"1972","unstructured":"Fraser D, Russell RGG, Pohler P, Robertson WG, Fleisch H (1972) The influence of a diphosphonate (ethane-1-hydroxy-1,1-diphosphonate) on the development of experimentally-induced urinary stones in rats. Clin Sci 42:197\u2013207","journal-title":"Clin Sci"},{"key":"953_CR77","first-page":"807","volume-title":"Biological mineralisation","author":"RGG Russell","year":"1973","unstructured":"Russell RGG, Robertson WG, Fleisch H (1973) Inhibitors of mineralisation. In: Zipkin I (ed) Biological mineralisation. Wiley, New York, pp 807\u2013825"},{"key":"953_CR78","first-page":"13","volume":"47","author":"WG Robertson","year":"1974","unstructured":"Robertson WG, Peacock M, Marshall RW, Knowles F (1974) The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stone-formers. Clin Sci Mol Med 47:13\u201322","journal-title":"Clin Sci Mol Med"},{"key":"953_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20780","volume":"20","author":"S Davis","year":"2016","unstructured":"Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M, Strong M, Selby P, Gittoes N (2016) A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technol Assess 20:1\u2013406","journal-title":"Health Technol Assess"},{"key":"953_CR80","first-page":"PC17","volume":"3","author":"SE Allen","year":"2006","unstructured":"Allen SE, Choong S, Fry C, Robertson WG (2006) The inhibitory effect of bisphosphonates on calcium oxalate crystal formation in vitro. Proc Physiol Soc 3:PC17","journal-title":"Proc Physiol Soc"},{"key":"953_CR81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000151413","volume":"81","author":"EK Basok","year":"2008","unstructured":"Basok EK, Basaran A, Atsu N, Yildirim A, Tokuc R (2008) Are new-generation bisphosphonates effective for the inhibition of calcium oxalate stone formation in a rat model? Urol Int 81:325\u2013329","journal-title":"Urol Int"},{"key":"953_CR82","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/215751a0","volume":"215","author":"R Dyer","year":"1967","unstructured":"Dyer R, Nordin BEC (1967) Urinary crystals and their relation to stone formation. Nature 215:751\u2013752","journal-title":"Nature"},{"key":"953_CR83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0140-6736(69)92598-7","volume":"2","author":"WG Robertson","year":"1969","unstructured":"Robertson WG, Peacock M, Nordin BEC (1969) Calcium crystalluria in recurrent renal stone-formers. Lancet 2:21\u201324","journal-title":"Lancet"},{"key":"953_CR84","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/cs0400365","volume":"40","author":"WG Robertson","year":"1971","unstructured":"Robertson WG, Peacock M, Nordin BEC (1971) Calcium oxalate crystalluria and urine saturation in recurrent stone-formers. Clin Sci 40:365\u2013374","journal-title":"Clin Sci"},{"key":"953_CR85","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/cs0430499","volume":"43","author":"WG Robertson","year":"1972","unstructured":"Robertson WG, Peacock M (1972) Calcium oxalate crystalluria and inhibitors of crystallisation in recurrent renal stone-formers. Clin Sci 43:499\u2013506","journal-title":"Clin Sci"},{"key":"953_CR86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0009-8981(73)90114-9","volume":"43","author":"WG Robertson","year":"1973","unstructured":"Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31\u201337","journal-title":"Clin Chim Acta"},{"key":"953_CR87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ki.1990.7","volume":"37","author":"DJ Kok","year":"1990","unstructured":"Kok DJ, Papapoulos SE, Bijvoet OLM (1990) Crystal agglomeration is a major element in calcium oxalate urinary stone-formation. Kidney Int 37:51\u201356","journal-title":"Kidney Int"},{"key":"953_CR88","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ki.1994.341","volume":"46","author":"DJ Kok","year":"1994","unstructured":"Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847\u2013854","journal-title":"Kidney Int"},{"key":"953_CR89","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/cs0680369","volume":"68","author":"RW Norman","year":"1985","unstructured":"Norman RW, Scurr DS, Robertson WG, Peacock M (1985) Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo. Clin Sci 68:369\u2013371","journal-title":"Clin Sci"},{"key":"953_CR90","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1464-410X.1984.tb06124.x","volume":"56","author":"RW Norman","year":"1984","unstructured":"Norman RW, Scurr DS, Robertson WG, Peacock M (1984) Inhibition of calcium oxalate crystallization by pentosan polysulphate in control subjects and stone-formers. Br J Urol 56:595\u2013598","journal-title":"Br J Urol"},{"key":"953_CR91","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0022-5347(17)38120-X","volume":"146","author":"S Kumar","year":"1991","unstructured":"Kumar S, Sigmon D, Miller T, Carpenter B, Khan S, Malhotra R, Scheid C, Menon M (1991) A new model of nephrolithiasis involving tubular dysfunction\/injury. J Urol 146:1384\u20131389","journal-title":"J Urol"},{"key":"953_CR92","doi-asserted-by":"crossref","first-page":"F192","DOI":"10.1152\/ajpcell.1996.270.1.C192","volume":"270","author":"JC Lieske","year":"1996","unstructured":"Lieske JC, Leonard R, Swift HS, Toback FG (1996) Adhesion of calcium oxalate monohydrate crystals to anionic sites of renal epithelial cells. Am J Physiol 270:F192\u2013F199","journal-title":"Am J Physiol"},{"key":"953_CR93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/ki.1996.60","volume":"49","author":"C Scheid","year":"1996","unstructured":"Scheid C, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, Jonassen J, Menon M (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49:413\u2013419","journal-title":"Kidney Int"},{"key":"953_CR94","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0022-5347(01)62607-7","volume":"160","author":"MW Bigelow","year":"1998","unstructured":"Bigelow MW, Wiessner JH, Kleinman JG, Mandel NS (1998) Calcium oxalate crystal attachment to cultured kidney epithelial cell lines. J Urol 160:1528\u20131532","journal-title":"J Urol"},{"key":"953_CR95","doi-asserted-by":"crossref","first-page":"F958","DOI":"10.1152\/ajpcell.1998.274.4.C958","volume":"274","author":"CF Verkoelen","year":"1998","unstructured":"Verkoelen CF, van der Boom BG, Houtsmuller AB, Schr\u00f6der FH, Romijn JC (1998) Increased calcium oxalate monohydrate crystal binding to injured tubular epithelial cells in culture. Am J Physiol 274:F958\u2013F965","journal-title":"Am J Physiol"},{"key":"953_CR96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcis.2006.03.070","volume":"300","author":"YI Rabinovich","year":"2006","unstructured":"Rabinovich YI, Esayanur M, Daosukho S, Byer KJ, El-Shall HE, Khan SR (2006) Adhesion force between calcium oxalate monohydrate crystal and kidney epithelial cells and possible relevance for kidney stone formation. J Colloid Interface Sci 300:131\u2013140","journal-title":"J Colloid Interface Sci"},{"key":"953_CR97","first-page":"1","volume":"83","author":"SR Khan","year":"2011","unstructured":"Khan SR (2011) Crystal\/cell interaction and nephrolithiasis. Arch Ital Urol Androl 83:1\u20135","journal-title":"Arch Ital Urol Androl"},{"key":"953_CR98","first-page":"442","volume":"15","author":"B Finlayson","year":"1978","unstructured":"Finlayson B, Reid F (1978) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442\u2013448","journal-title":"Invest Urol"},{"key":"953_CR99","doi-asserted-by":"crossref","first-page":"F604","DOI":"10.1152\/ajpcell.1995.268.3.C604","volume":"268","author":"JC Lieske","year":"1995","unstructured":"Lieske JC, Leonard R, Toback FG (1995) Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604\u2013F612","journal-title":"Am J Physiol"},{"key":"953_CR100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00240-005-0492-4","volume":"33","author":"SR Khan","year":"2005","unstructured":"Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349\u2013357","journal-title":"Urol Res"},{"key":"953_CR101","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI17038","volume":"111","author":"AP Evan","year":"2003","unstructured":"Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall\u2019s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607\u2013616","journal-title":"J Clin Invest"},{"key":"953_CR102","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1523-1755.2005.67114.x","volume":"67","author":"AP Evan","year":"2005","unstructured":"Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576\u2013591","journal-title":"Kidney Int"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-016-0953-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00240-016-0953-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-016-0953-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T02:16:02Z","timestamp":1568600162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00240-016-0953-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s00240-016-0953-y","relation":{},"ISSN":["2194-7228","2194-7236"],"issn-type":[{"value":"2194-7228","type":"print"},{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}